Latest News

Hi-Q wins a Gold Award with our Innovation [Oligo Fucoidan, an Active Substance for Preventing Radiation-Induced Pneumonitis and Lung Fibrosis during Radiotherapy] at the Malaysia Technology Expo (MTE)! Hi-Q would like to express our special appreciation and thanks to Doctor Szu Yuan Wu, Director of Cancer Center (Lotung Poh-Ai Hospital), for his efforts in this research!

Milestones in cancer research and discovery! Oligo Fucoidan listed in U.S. National Cancer Institute Dictionary!

Hi-Q Marine Biotech, in collaboration with Shanghai Zhongshan Hospital of Fudan University and Institute of Liver Diseases, Shanghai Jiao Tong University, presents groundbreaking research on fucoidan's potential in combating hepatocellular carcinoma (HCC).

The SNQ Certification is given by Institute for Biotechnology and Medicine Industry, products certified with the SNQ designation are evaluated by a panel of scholars and experts, including doctors, professors, and researchers, against a number of scientific, efficacy, and strict quality criteria. This certification is awarded yearly and is the most trusted symbol of safety and quality for health supplement and biotechnology products in Taiwan.

Dr. Gerald Post and his team from The Veterinary Cancer Center (VCC, USA) evaluated the effect of oligo fucoidan on the quality of life in dogs with cancer undergoing chemotherapy in a double-blinded case control study.

Hi-Q is excited to announce the official launch of its dietary supplement product line on Rakuten's global e-commerce platform in Japan. This strategic move marks a significant milestone for the company, as it expands its reach into the thriving Japanese market.